ENTITY

Genematrix Inc (109820 KS)

Health Care • South Korea

Genematrix Inc. provides diagnostics & therapeutic solution. The Company's services are based on Restriction Fragment Mass Polymorphism (RFMP) technology and applied to theranostics, prognosis, and molecular diagnosis.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00